FDA recall, , Moderate risk
South Texas Blood & Tissue Pooled Platelets and Red Blood Cells
Pooled platelets and red blood cells were collected from a donor in a malaria endemic area.
Recall ended Sep 30, 2026. Still check yours.
What happened
South Texas Blood & Tissue Center began a recall on May 11, 2026, for pooled platelets and Red Blood Cells, Leukocytes Reduced, each with a quantity of 1, because they were collected from a donor who was a resident of a malaria endemic area and were distributed in Texas. The FDA classified the recall on September 30, 2026, and added it to its Enforcement Report on October 1, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor who was a resident of a malaria endemic area, were distributed.
Pooled Platelets
Reason: Pooled platelets, collected from a donor who was a resident of a malaria endemic area, were distributed.
Recall details
- Company began the recall
- Sold in
- Company
- South Texas Blood & Tissue Center
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99741
- Recall numbers
- B-0284-2026 to B-0285-2026
All recalls from South Texas Blood & Tissue Center
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Classified by FDA · Recall ended
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
Summary updated

